Senseonics (NYSE:SENS) announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) ...
Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Paige DeSorbo relies on these sticky push up bra inserts to give her girls ‘a little lift’ and they’re just $17 on Amazon — ...
Parent company Liberated Brands blamed fast fashion and e-commerce moving too quickly to sustain its outdated ...
DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...
Zacks.com on MSN22h
DexCom (DXCM) Q4 Earnings Preview: What's in the Cards?Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when DexCom (DXCM) reports results for the quarter ended December 2024. While this widely-known consensus outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback